Literature DB >> 26983727

An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.

Philip D Minor1.   

Abstract

Poliomyelitis is caused by poliovirus, which is a positive strand non-enveloped virus that occurs in three distinct serotypes (1, 2, and 3). Infection is mainly by the fecal-oral route and can be confined to the gut by antibodies induced either by vaccine, previous infection or maternally acquired. Vaccines include the live attenuated strains developed by Sabin and the inactivated vaccines developed by Salk; the live attenuated vaccine (Oral Polio Vaccine or OPV) has been the main tool in the Global Program of Polio eradication of the World Health Organisation. Wild type 2 virus has not caused a case since 1999 and type 3 since 2012 and eradication seems near. However most infections are entirely silent so that sophisticated environmental surveillance may be needed to ensure that the virus has been eradicated, and the live vaccine can sometimes revert to virulent circulating forms under conditions that are not wholly understood. Cessation of vaccination is therefore an increasingly important issue and inactivated polio vaccine (IPV) is playing a larger part in the end game.

Entities:  

Keywords:  Human enterovirus C species pathogenesis; Live and killed vaccines; Picornaviruses; Poliovirus; Stopping vaccination; The Global Poliomyelitis Eradication Initiative; Vaccine derived polioviruses

Mesh:

Substances:

Year:  2016        PMID: 26983727     DOI: 10.1007/978-1-4939-3292-4_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Designing multivalent immunogens for alphavirus vaccine optimization.

Authors:  C M Read; Kenneth Plante; Grace Rafael; Shannan L Rossi; Werner Braun; Scott C Weaver; Catherine H Schein
Journal:  Virology       Date:  2021-02-05       Impact factor: 3.513

2.  Comparative analysis of virus-host interactions caused by a virulent and an attenuated duck hepatitis A virus genotype 1.

Authors:  Xumin Ou; Sai Mao; Jingyu Cao; Anchun Cheng; Mingshu Wang; Dekang Zhu; Shun Chen; Renyong Jia; Mafeng Liu; Kunfeng Sun; Qiao Yang; Ying Wu; Xiaoyue Chen
Journal:  PLoS One       Date:  2017-06-14       Impact factor: 3.240

3.  A novel gamma radiation-inactivated sabin-based polio vaccine.

Authors:  Gregory J Tobin; John K Tobin; Elena K Gaidamakova; Taralyn J Wiggins; Ruth V Bushnell; Wai-Ming Lee; Vera Y Matrosova; Stephen J Dollery; Heather N Meeks; Diana Kouiavskaia; Konstantin Chumakov; Michael J Daly
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

Review 4.  COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.

Authors:  Young Hun Chung; Veronique Beiss; Steven N Fiering; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2020-10-09       Impact factor: 15.881

5.  Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines.

Authors:  Mohammad W Bahar; Claudine Porta; Helen Fox; Andrew J Macadam; Elizabeth E Fry; David I Stuart
Journal:  NPJ Vaccines       Date:  2021-01-08       Impact factor: 7.344

6.  Incompatible Translation Drives a Convergent Evolution and Viral Attenuation During the Development of Live Attenuated Vaccine.

Authors:  Xumin Ou; Mingshu Wang; Sai Mao; Jingyu Cao; Anchun Cheng; Dekang Zhu; Shun Chen; Renyong Jia; Mafeng Liu; Qiao Yang; Ying Wu; Xinxin Zhao; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Xiaoyue Chen; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Front Cell Infect Microbiol       Date:  2018-07-18       Impact factor: 5.293

7.  Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.

Authors:  Christopher van Hoorebeke; ChunHong Huang; Sean Leary; Marisa Holubar; Jonathan Altamirano; Meira S Halpern; Marvin Sommer; Yvonne Maldonado
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.